126 related articles for article (PubMed ID: 37931881)
1. Studying longitudinal neutralising antibody levels against Equid herpesvirus 1 in experimentally infected horses using a novel pseudotype based assay.
Di Genova C; Sutton G; Paillot R; Temperton N; Pronost S; Scott SD
Virus Res; 2024 Jan; 339():199262. PubMed ID: 37931881
[TBL] [Abstract][Full Text] [Related]
2. Virological and serological investigation of Equid herpesvirus 1 infection in New Zealand.
Dunowska M; Gopakumar G; Perrott MR; Kendall AT; Waropastrakul S; Hartley CA; Carslake HB
Vet Microbiol; 2015 Apr; 176(3-4):219-28. PubMed ID: 25666453
[TBL] [Abstract][Full Text] [Related]
3. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR.
Ataseven VS; Dağalp SB; Güzel M; Başaran Z; Tan MT; Geraghty B
Res Vet Sci; 2009 Apr; 86(2):339-44. PubMed ID: 18649902
[TBL] [Abstract][Full Text] [Related]
5. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody.
Ruitenberg KM; Love DN; Gilkerson JR; Wellington JE; Whalley JM
Vet Microbiol; 2000 Sep; 76(2):117-27. PubMed ID: 10946142
[TBL] [Abstract][Full Text] [Related]
6. Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins.
Azab W; Osterrieder N
J Virol; 2012 Feb; 86(4):2031-44. PubMed ID: 22171258
[TBL] [Abstract][Full Text] [Related]
7. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
[TBL] [Abstract][Full Text] [Related]
8. Use of the meridian test for the detection of equine herpesvirus type 1 infection in horses with decreased performance.
Chvala S; Nowotny N; Kotzab E; Cain M; van den Hoven R
J Am Vet Med Assoc; 2004 Aug; 225(4):554-9. PubMed ID: 15344363
[TBL] [Abstract][Full Text] [Related]
9. The role of glycoprotein H of equine herpesviruses 1 and 4 (EHV-1 and EHV-4) in cellular host range and integrin binding.
Azab W; Zajic L; Osterrieder N
Vet Res; 2012 Aug; 43(1):61. PubMed ID: 22909178
[TBL] [Abstract][Full Text] [Related]
10. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
11. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of the Equid Herpesvirus 2 and 5 Infections among Mares and Foals from Three Polish National Studs.
Stasiak K; Dunowska M; Rola J
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458443
[TBL] [Abstract][Full Text] [Related]
13. Equine herpesvirus infections in yearlings in South-East Queensland.
Diallo IS; Hewitson GR; de Jong A; Kelly MA; Wright DJ; Corney BG; Rodwell BJ
Arch Virol; 2008; 153(9):1643-9. PubMed ID: 18677574
[TBL] [Abstract][Full Text] [Related]
14. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
[TBL] [Abstract][Full Text] [Related]
15. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
16. Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.
Gildea S; Sanchez Higgins MJ; Johnson G; Walsh C; Cullinane A
Influenza Other Respir Viruses; 2016 Sep; 10(5):433-7. PubMed ID: 27169603
[TBL] [Abstract][Full Text] [Related]
17. Induction of a Th-1-biased IgG subclass response against equine herpesvirus type 1 in horses previously infected with type 4 virus.
Bannai H; Tsujimura K; Kondo T; Nemoto M; Yamanaka T; Sugiura T; Maeda K; Matsumura T
J Vet Med Sci; 2011 Apr; 73(4):535-9. PubMed ID: 21139350
[TBL] [Abstract][Full Text] [Related]
18. Comparison of four methods to quantify Equid herpesvirus 1 load by real-time polymerase chain reaction in nasal secretions of experimentally and naturally infected horses.
Pusterla N; Hussey SB; Mapes S; Leutenegger CM; Madigan JE; Ferraro GL; Wilson WD; Lunn DP
J Vet Diagn Invest; 2009 Nov; 21(6):836-40. PubMed ID: 19901285
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of glycoprotein B (gB) of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in cellular tropism and cell-to-cell transmission.
Spiesschaert B; Osterrieder N; Azab W
Viruses; 2015 Feb; 7(2):522-42. PubMed ID: 25654240
[TBL] [Abstract][Full Text] [Related]
20. Lyophilisation of influenza, rabies and Marburg lentiviral pseudotype viruses for the development and distribution of a neutralisation -assay-based diagnostic kit.
Mather ST; Wright E; Scott SD; Temperton NJ
J Virol Methods; 2014 Dec; 210():51-8. PubMed ID: 25286181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
